Advertisement

Related Videos

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Gary L. Rosner, ScD, on Bayesian Non-Inferiority

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Advertisement

Advertisement




Sep
03
Today In Oncology
ADC/Immunotherapy Combination Shows Activity in Treatment-Resistant Nasopharyngeal Carcinoma
Hypofractionated Salvage Radiotherapy Evaluated After Prostatectomy for Biochemical Recurrence
Dual Oral Regimen Shows Encouraging Activity in KRAS G12C–Mutated Metastatic Colorectal Cancer
Researchers Define Molecular Prognostic Subgroups in Therapy-Related Myeloid Neoplasms
ACS Publishes Report on Cancers in Asian American, Native Hawaiian, and Pacific Islander People
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo